Mona M. AbouSamra

592 total citations
22 papers, 402 citations indexed

About

Mona M. AbouSamra is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Mona M. AbouSamra has authored 22 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Mona M. AbouSamra's work include Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Drug Solubulity and Delivery Systems (3 papers). Mona M. AbouSamra is often cited by papers focused on Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Drug Solubulity and Delivery Systems (3 papers). Mona M. AbouSamra collaborates with scholars based in Egypt and Germany. Mona M. AbouSamra's co-authors include Alaa H. Salama, Soheir S. Mansy, Amira Mohamed Mohsen, Mona Basha, Ghada E. A. Awad, Shaimaa ElShebiney, Azza A. Matloub, Ghada E. A. Awad, Rabab Kamel and Sherif M. Afifi and has published in prestigious journals such as Scientific Reports, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Mona M. AbouSamra

20 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona M. AbouSamra Egypt 13 193 74 73 58 36 22 402
Ayman Salama Egypt 11 251 1.3× 97 1.3× 73 1.0× 69 1.2× 26 0.7× 25 515
Gehan F. Balata Egypt 13 316 1.6× 105 1.4× 88 1.2× 67 1.2× 30 0.8× 30 527
Walaa A. Abualsunun Saudi Arabia 14 145 0.8× 72 1.0× 43 0.6× 60 1.0× 28 0.8× 26 396
Alshaimaa M. Almehmady Saudi Arabia 14 197 1.0× 92 1.2× 55 0.8× 79 1.4× 54 1.5× 25 459
Swati Sharma India 14 236 1.2× 131 1.8× 92 1.3× 55 0.9× 54 1.5× 32 573
Maha M. A. Nasra Egypt 13 251 1.3× 115 1.6× 68 0.9× 42 0.7× 78 2.2× 18 526
Samar S. A. Murshid Saudi Arabia 13 140 0.7× 69 0.9× 58 0.8× 59 1.0× 21 0.6× 25 349
Prakash Goudanavar India 11 160 0.8× 62 0.8× 72 1.0× 38 0.7× 25 0.7× 81 461
Vijay Sharma India 13 254 1.3× 82 1.1× 56 0.8× 67 1.2× 44 1.2× 37 539
Waleed S. Alharbi Saudi Arabia 16 219 1.1× 155 2.1× 92 1.3× 80 1.4× 73 2.0× 35 607

Countries citing papers authored by Mona M. AbouSamra

Since Specialization
Citations

This map shows the geographic impact of Mona M. AbouSamra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona M. AbouSamra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona M. AbouSamra more than expected).

Fields of papers citing papers by Mona M. AbouSamra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona M. AbouSamra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona M. AbouSamra. The network helps show where Mona M. AbouSamra may publish in the future.

Co-authorship network of co-authors of Mona M. AbouSamra

This figure shows the co-authorship network connecting the top 25 collaborators of Mona M. AbouSamra. A scholar is included among the top collaborators of Mona M. AbouSamra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona M. AbouSamra. Mona M. AbouSamra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Marasy, Salma A., et al.. (2024). Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway. Scientific Reports. 14(1). 13559–13559.
2.
3.
El‐Marasy, Salma A., et al.. (2023). Chrysin loaded nanovesicles ameliorated diabetic peripheral neuropathy. Role of NGF/AKT/GSK-3β pathway. Chemico-Biological Interactions. 375. 110402–110402. 12 indexed citations
4.
AbouSamra, Mona M., Rania Elgohary, & Soheir S. Mansy. (2022). Innovated pirfenidone loaded lecithin nanocapsules for targeting liver fibrosis: Formulation, characterization and in vivo study. International Journal of Pharmaceutics. 631. 122539–122539. 8 indexed citations
5.
6.
Kamel, Rabab, et al.. (2022). Phyto-emulsomes as a novel nano-carrier for morine hydrate to combat leukemia: In vitro and pharmacokinetic study. Journal of Drug Delivery Science and Technology. 75. 103700–103700. 6 indexed citations
7.
8.
Mansy, Soheir S. & Mona M. AbouSamra. (2022). Electron microscopy overview of SARS-COV2 and its clinical impact. Ultrastructural Pathology. 46(1). 1–17. 2 indexed citations
9.
AbouSamra, Mona M., et al.. (2022). Rutin-loaded Phyto-Sterosomes as a potential approach for the treatment of hepatocellular carcinoma: In-vitro and in-vivo studies. Journal of Drug Delivery Science and Technology. 79. 104015–104015. 14 indexed citations
10.
Salama, Alaa H., Mona M. AbouSamra, Ghada E. A. Awad, & Soheir S. Mansy. (2020). Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation. Drug Delivery and Translational Research. 11(5). 1943–1957. 28 indexed citations
11.
AbouSamra, Mona M., Alaa H. Salama, Ghada E. A. Awad, & Soheir S. Mansy. (2020). Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine. AAPS PharmSciTech. 21(7). 283–283. 14 indexed citations
12.
Khalil, Rawia M., et al.. (2020). Development of Lecithin/Chitosan Nanoparticles for Promoting Topical Delivery of Propranolol Hydrochloride: Design, Optimization and In-Vivo Evaluation. Journal of Pharmaceutical Sciences. 110(3). 1337–1348. 18 indexed citations
13.
AbouSamra, Mona M., Mona Basha, Ghada E. A. Awad, & Soheir S. Mansy. (2018). A promising nystatin nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis. Journal of Drug Delivery Science and Technology. 49. 365–374. 29 indexed citations
14.
Basha, Mona, Mona M. AbouSamra, Ghada E. A. Awad, & Soheir S. Mansy. (2018). A potential antibacterial wound dressing of cefadroxil chitosan nanoparticles in situ gel: Fabrication, in vitro optimization and in vivo evaluation. International Journal of Pharmaceutics. 544(1). 129–140. 49 indexed citations
15.
Matloub, Azza A., Mona M. AbouSamra, Alaa H. Salama, et al.. (2017). Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciata with potent antihyperlipidaemic activity. Saudi Pharmaceutical Journal. 26(2). 224–231. 39 indexed citations
16.
Mohsen, Amira Mohamed, Mona M. AbouSamra, & Shaimaa ElShebiney. (2017). Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation:in-vitrocharacterization andin-vivoevaluation. Drug Development and Industrial Pharmacy. 43(8). 1254–1264. 51 indexed citations
17.
Matloub, Azza A., et al.. (2017). Exploiting bilosomes for delivering bioactive polysaccharide isolated fromEnteromorpha intestinalisfor hacking hepatocellular carcinoma. Drug Development and Industrial Pharmacy. 44(4). 523–534. 36 indexed citations
18.
AbouSamra, Mona M., Mona Basha, Sally A. El Awdan, & Nasser S. M. Ismail. (2016). EFFECT OF METHYL-Β-CYCLODEXTRIN COMPLEXATION ON THE HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF KHELLIN: EXPERIMENTAL STUDY. International Journal of Pharmacy and Pharmaceutical Sciences. 8(11). 165–165. 6 indexed citations
19.
AbouSamra, Mona M. & Alaa H. Salama. (2016). Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. Journal of Liposome Research. 27(4). 324–334. 33 indexed citations
20.
AbouSamra, Mona M. & Amira Mohamed Mohsen. (2015). SOLID LIPID NANOPARTICLES AND NANOSTRUCTURED LIPID CARRIERS OF TOLNAFTATE: DESIGN, OPTIMIZATION AND IN-VITRO EVALUATION. International Journal of Pharmacy and Pharmaceutical Sciences. 8(1). 380–385. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayman Salama Breakdown of academic impact, for papers by Gehan F. Balata Breakdown of academic impact, for papers by Walaa A. Abualsunun Breakdown of academic impact, for papers by Alshaimaa M. Almehmady Breakdown of academic impact, for papers by Swati Sharma Breakdown of academic impact, for papers by Maha M. A. Nasra Breakdown of academic impact, for papers by Samar S. A. Murshid Breakdown of academic impact, for papers by Prakash Goudanavar Breakdown of academic impact, for papers by Vijay Sharma Breakdown of academic impact, for papers by Waleed S. Alharbi
Rankless by CCL
2026